Abstract:Postoperative continuous venovenous hemofiltration decreases acute renal failure in patients with moderate renal dysfunction undergoing coronary artery bypass grafting, but it prolongs intensive care unit stay. We developed a simple method to connect a hemofiltration machine to the cardiopulmonary bypass system. To evaluate the benefit of intraoperative hemofiltration, 124 consecutive patients (mean age, 67 +/- 6 years) with moderate renal dysfunction were studied. Surgery was preformed between January 2005 an… Show more
“…One study evaluated the effect of prophylactic hemofiltration on postoperative renal function in 124 consecutive patients with moderate preoperative renal dysfunction. The results showed that the patients with intraoperative prophylactic hemofiltration had better protection of renal function than the patients in the group without prophylactic hemofiltration [123]. A retrospective observational multicenter study enrolled data from 24 Spanish hospitals with 203 patients with AKI-RRT after cardiac surgery.…”
Section: Prophylactic and Therapeutic Blood Purificationmentioning
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common and serious postoperative complication of cardiac surgery requiring cardiopulmonary bypass (CPB), and it is the second most common cause of AKI in the intensive care unit. Although the complication has been associated with the use of CPB, the etiology is likely multifactorial and related to intraoperative and early postoperative management including pharmacologic therapy. To date, very little evidence from randomized trials supporting specific interventions to protect from or prevent AKI in broad cardiac surgery populations has been found. The definition of AKI employed by investigators influences not only the incidence of CSA-AKI, but also the identification of risk variables. The advent of novel biomarkers of kidney injury has the potential to facilitate the subclinical diagnosis of CSA-AKI, the assessment of its severity and prognosis, and the early institution of interventions to prevent or reduce kidney damage. Further studies are needed to determine how to optimize cardiac surgical procedures, CPB parameters, and intraoperative and early postoperative blood pressure and renal blood flow to reduce the risk of CSA-AKI. No pharmacologic strategy has demonstrated clear efficacy in the prevention of CSA-AKI; however, some agents, such as the natriuretic peptide nesiritide and the dopamine agonist fenoldopam, have shown promising results in renoprotection. It remains unclear whether CSA-AKI patients can benefit from the early institution of such pharmacologic agents or the early initiation of renal replacement therapy.
“…One study evaluated the effect of prophylactic hemofiltration on postoperative renal function in 124 consecutive patients with moderate preoperative renal dysfunction. The results showed that the patients with intraoperative prophylactic hemofiltration had better protection of renal function than the patients in the group without prophylactic hemofiltration [123]. A retrospective observational multicenter study enrolled data from 24 Spanish hospitals with 203 patients with AKI-RRT after cardiac surgery.…”
Section: Prophylactic and Therapeutic Blood Purificationmentioning
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common and serious postoperative complication of cardiac surgery requiring cardiopulmonary bypass (CPB), and it is the second most common cause of AKI in the intensive care unit. Although the complication has been associated with the use of CPB, the etiology is likely multifactorial and related to intraoperative and early postoperative management including pharmacologic therapy. To date, very little evidence from randomized trials supporting specific interventions to protect from or prevent AKI in broad cardiac surgery populations has been found. The definition of AKI employed by investigators influences not only the incidence of CSA-AKI, but also the identification of risk variables. The advent of novel biomarkers of kidney injury has the potential to facilitate the subclinical diagnosis of CSA-AKI, the assessment of its severity and prognosis, and the early institution of interventions to prevent or reduce kidney damage. Further studies are needed to determine how to optimize cardiac surgical procedures, CPB parameters, and intraoperative and early postoperative blood pressure and renal blood flow to reduce the risk of CSA-AKI. No pharmacologic strategy has demonstrated clear efficacy in the prevention of CSA-AKI; however, some agents, such as the natriuretic peptide nesiritide and the dopamine agonist fenoldopam, have shown promising results in renoprotection. It remains unclear whether CSA-AKI patients can benefit from the early institution of such pharmacologic agents or the early initiation of renal replacement therapy.
“…A retrospective cohort study of 220 patients (aged 10 days to 19 years) demonstrated that an increase in Hb of >3g/dL from preoperative value on POD 1 was a significant risk factor (adjusted OR:6.94 [95% CI 2.33-20.69]) in the development of CS-AKI. 29 The effect of other modifications in CPB techniques, such as utilization of pulsatile CPB, 127 ultrafiltration, 128 and hemofiltration 129 during CPB on CS-AKI have only been predominantly described in the adult cardiac population. However, these have not been widely studied in children.…”
Section: Specific Strategies Of Cpb Supportmentioning
Children undergoing cardiac surgery are at risk of developing acute kidney injury (AKI). Preventing cardiac surgery-associated AKI (CS-AKI) is important as it is associated with increased early- and long-term mortality and morbidity. Targeting modifiable risk factors (eg, avoiding poor renal perfusion, nephrotoxic drugs, and fluid overload) reduces the risk of CS-AKI. There is currently no strong evidence for the routine use of pharmacological approaches (eg, aminophylline, dexmedetomidine, fenoldopam, and steroids) to prevent CS-AKI. There is robust evidence to support the role of early peritoneal dialysis as a nonpharmacologic approach to prevent CS-AKI.
“…и подключением ГФ во время ИК, СКФ по сле КШ снижалась незначительно, была сравнима с та ковой при операциях КШ «of pump». В группе ИК без ГФ, СКФ после операции была достоверно ниже [7]. В наше исследование включено меньше пациентов, кроме операций КШ имели место вмешательства на клапанах сердца и левом желудочке, доза замещения несколько больше, чем в приведенном исследовании.…”
Section: результаты и обсуждениеunclassified
“…В качестве профилактики ухудшения функции почек, развития послеоперационной ОПН у больных высоко го риска предложена интраоперационная ГФ [7]. В слу чае развития ОПН, процедуры ЗПТ применяют на ос новании абсолютных показаний и оценки тяжести ОПН согласно классификаций RIFLE (2004), AKIN (2007) [8].…”
Цель исследования -анализ эффективности гемофильтрации (ГФ) на этапе искусственного кровообращения (ИК) при операциях на сердце, для профилактики острого снижения функции почек и развития острой почечной недоста точности (ОПН).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.